Jul 18 |
U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract
|
Jun 27 |
Applied DNA Sciences (APDN) Upgraded to Buy: What Does It Mean for the Stock?
|
Jun 27 |
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
|
Jun 20 |
Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics
|
Jun 18 |
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing
|
Jun 13 |
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health
|
Jun 5 |
Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform
|
May 28 |
Top Midday Decliners
|
May 28 |
Applied DNA Sciences Prices $12 Million Public Offering of Units
|
May 28 |
Applied DNA stock plunges after pricing $12M securities offering
|